Dose escalation of eribulin + cisplatin as induction chemotherapy in chemo-refractory triple negative breast cancer

Authors :: Masae Torii
Masakazu Toi
Hiroshi Ishiguro
Masahiro Kawashima
Ayane Yamaguchi
M. Takada
Source :: Annals of Oncology. 26:vii127
Publication Year :: 2015
Publisher :: Elsevier BV, 2015.

Subjects :: Oncology
Cisplatin
medicine.medical_specialty
business.industry
Induction chemotherapy
Hematology
Chemotherapy regimen
chemistry.chemical_compound
chemistry
Refractory
Internal medicine
medicine
business
Triple-negative breast cancer
Eribulin
medicine.drug

Full Text Access

Tools